Literature DB >> 1793023

Corticosteroids and immunosuppressive agents in rabbit heterolamellar corneal transplant model.

E Ohia1, P Kulkarni.   

Abstract

Bovine cornea (epithelium and stroma) was transplanted on to the rabbit cornea from which the epithelium and stroma had been removed. Conjuntival hyperemia and edema occurred from day 1-5 post-operation, followed by neovascularization and graft rejection within 7-10 days. Topical dexamethasone (0.1%) and prenisolone (1%) t.i.d. inhibited post-surgical hyperemia, edema, delayed hypersensitivity and neovascularization. These agents and the immunosuppressants (cyclosporin A and rapamycin) inhibited graft rejection observed up to 20 days. After cessation of treatment on the 20th day, grafts remained viable up to 35 days with dexamethasone, 10 days with prednisolone and rapamycin, and 5 days with cyclosporin A.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1793023     DOI: 10.1007/bf01993267

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  4 in total

1.  Effects of anti-inflammatory and immunosuppressive drugs on the heterolamellar corneal transplantation in rabbits.

Authors:  A Guo; E Ohia; J T Xu; P Bhattacherjee; P Kulkarni
Journal:  Curr Eye Res       Date:  1990-08       Impact factor: 2.424

2.  Anti-inflammatory effects of betamethasone phosphate, dexamethasone phosphate and indomethacin on rabbit ocular inflammation induced by bovine serum albumin.

Authors:  P S Kulkarni; P Bhattacherjee; K E Eakins; B D Srinivasan
Journal:  Curr Eye Res       Date:  1981       Impact factor: 2.424

3.  Inhibition of the immune response by rapamycin, a new antifungal antibiotic.

Authors:  R R Martel; J Klicius; S Galet
Journal:  Can J Physiol Pharmacol       Date:  1977-02       Impact factor: 2.273

4.  Effect of cyclosporin A on the survival of corneal grafts in rabbits.

Authors:  W F Shepherd; D J Coster; T C Fook; N S Rice; B R Jones
Journal:  Br J Ophthalmol       Date:  1980-03       Impact factor: 4.638

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.